I asked Tony about this a couple of months back and he explained that they prefer to wait for FDA approval. Right now, telehealth companies will push hard for exclusivity deals. Once FDA is granted no one can reasonably ask for exclusivity. We want all telehealth vendors to be signing contracts with us.
As painful as this last month is, its going to be worth the wait. In the past RAP has traded on anticipation, so i think the only thing keeping the brakes on the SP at the moment is this rubbish market out there at the moment for *********. Anything that is holding up ok, people are selling to get in on the host of other bargains out there. But i still believe this will take off prior to announcements
- Forums
- ASX - By Stock
- RAP
- Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest
Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-161
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online